CliffBio
small molecule

METOPIRONE

METYRAPONE

Loss of exclusivity—loss of exclusivity
CompanyEsteve →See this company's full patent-cliff portfolio

Drug detail

Brand nameMETOPIRONE
Active ingredientMETYRAPONE
Strength250MG
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalAugust 1996
Marketing statusRX

More from Esteve

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

METOPIRONE patent cliff — loss of exclusivity — | CliffBio